A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2006
11/29/2006	EP1387699B1 Agent for improving tissue penetration
11/29/2006	EP1313794B1 Elastomeric functional biodegradable copolyester amides and copolyester urethanes
11/29/2006	EP1301614B1 Codon-optimized papilloma virus sequences
11/29/2006	EP1280499B1 Polymeric delivery and release systems for oral care actives
11/29/2006	EP1259223A4 Protein matrix materials, devices and methods of making and using thereof
11/29/2006	EP1248650B1 Improved dna vaccines for bovine herpesvirus-1
11/29/2006	EP1158993B1 Bacterial membrane fractions with adjuvant effect
11/29/2006	EP1092027B1 Therapeutic and diagnostic domain 1 beta 2 gp1 polypeptides and methods of using same
11/29/2006	EP1024792B1 Topical antifungal composition
11/29/2006	EP1023049B1 Preparation of a directly mouldable tabletting auxiliary
11/29/2006	CN1871259A Improved antibodies having altered effector function and methods for making the same
11/29/2006	CN1871257A Interferon-beta composite
11/29/2006	CN1871032A Composite material comprising a porous semiconductor impregnated with an organic substance
11/29/2006	CN1871031A Compositions and methods for augmenting kidney function
11/29/2006	CN1871022A Peptides and compounds that bind to a receptor
11/29/2006	CN1871018A Pharmaceutical formulation comprising lanthanum compounds
11/29/2006	CN1871014A Pharmaceutical composition containing prostaglandin
11/29/2006	CN1870993A Pharmaceutical compositions based on idazoxan salt or one of the polymorphs thereof
11/29/2006	CN1870982A Composition containing reduced coenzyme q
11/29/2006	CN1870980A Controlled release sterile injectable aripiprazole formulation and method
11/29/2006	CN1870955A Kavalactone compositions and methods of use
11/29/2006	CN1869692A Three-function nano-ball
11/29/2006	CN1869128A Temperature sensing instant type gel system
11/29/2006	CN1869106A Method of preparing polymer nanometerl micron ball assisted by ultrasonic wave
11/29/2006	CN1869099A Method of preparing nanometer and micron self assembling body from poly peptide-b-polytetrahydrofuran-b-polypeptide triblock copolymer
11/29/2006	CN1869070A High efficiency low poison immune toxin and its preparation method and application
11/29/2006	CN1868544A Amino-acid modified chitin nucleophic NO donor and its synthesis method
11/29/2006	CN1868543A Biodegradable high molecular gel medicine composition, its prepn. method and use thereof
11/29/2006	CN1868542A Water system corn protein pseudo-emulsion and its prepn. method
11/29/2006	CN1868541A Chitin nanometer granule for programmable releasing various kinds of medicine, and its prepn. method
11/29/2006	CN1868483A Injection for treating eperythrozoonosis of domestic animal and its prepn. method
11/29/2006	CN1868477A Formula of Reynoldazine hydrochloride prepn.
11/29/2006	CN1868473A Compound medicine contg. famotidine cyclodextrin clathrate, and its prepn. method
11/29/2006	CN1868472A Tablets of Lizakuputan benzoate
11/29/2006	CN1868471A Methyl cantharis amine injection and its prepn. method
11/29/2006	CN1868470A Abiduoer granular formulation
11/29/2006	CN1868464A Piduomode soft capsule and its prepn. method
11/29/2006	CN1868463A Slow-release prepn. contg. alpha-lipoic acid or its derivatives, and preparing method therefor
11/29/2006	CN1868462A Bromhexine hydrochloride oral disintegrant tablet
11/29/2006	CN1868460A Doxycycline hydrochloride freeze-dried power prepn. for injection, and process for preparing same
11/29/2006	CN1868459A Docetaxel freeze-dried powder-injection, and its prepn. method
11/29/2006	CN1868458A Controlled release composition and method of producing the same
11/29/2006	CN1868457A Prepn. method of matrine magnetic micro-ball
11/29/2006	CN1868456A Prepn. of antisense deoxyoligonucleotide ISIS23665 elaioplast, and its prepn. method
11/29/2006	CN1868455A Intravenous nanometer suspension injection contg. oxaliplatin platinum phospholipid compound
11/29/2006	CN1868454A Slow-release injection contg. platinum compounds and its potentiator
11/29/2006	CN1868453A Slow-release injection contg. platinum compounds and cellulotoxic medicines
11/29/2006	CN1868452A Anticancer slow-release injection contg. platinum compounds
11/29/2006	CN1868450A Cream contg. doxepin hydrochloride, and its prepn. method
11/29/2006	CN1868449A Ganciclovir ophthalmic gel and its prepn. method
11/29/2006	CN1286969C Stabilizing diluent for polypeptides and antigens
11/29/2006	CN1286529C Skin targeting medicinal composition and its preparation and use
11/29/2006	CN1286528C Hollow fiber medicine carrier and its preparing method and use
11/29/2006	CN1286492C Traditional Chinese medicinal plaster
11/29/2006	CN1286467C Method for producing antibiotic preparation and its application
11/29/2006	CN1286462C Medical preparation for injection
11/29/2006	CN1286459C Transparent and disappearing external medicine preparation containing benzotolazo
11/29/2006	CN1286453C Method for stablizing protein medicine and its application in microball preparation
11/29/2006	CN1286451C Pharmaceutical formulation for efficient administration of apomorphine, 6aR-(-)-N-propyl-norepomorphine and their derivatives and pro-drugs thereof
11/28/2006	US7141555 Water solubility, bioavailability, oral administration; unit dosage
11/28/2006	US7141554 Method of treating irritable bowel syndrome
11/28/2006	US7141552 Use of lipid conjugates in the treatment of diseases
11/28/2006	US7141549 For diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins (SEC and NOV)
11/28/2006	US7141542 Biologically active protein useful for aerosol delivery to the respiratory tract
11/28/2006	US7141540 Used as bioactive agent carriers for drug delivery of paclitaxel
11/28/2006	US7141428 Methods for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof
11/28/2006	US7141375 Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
11/28/2006	US7141252 Composition for the treatment of burns, sunburns, abrasions, ulcers and cutaneous irritation
11/28/2006	US7141249 Rapidly soluble drug composition
11/28/2006	CA2301185C Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
11/28/2006	CA2150945C Ibuprofen-containing effervescent pharmaceutical composition and process for preparing the same
11/28/2006	CA2026915C Stem cell factor
11/23/2006	WO2006125134A1 Peptides whose uptake by cells is controllable
11/23/2006	WO2006124737A2 Molecular constructs suitable for targeted conjugates
11/23/2006	WO2006124630A2 Compositions and methods for enhancing the efficacy of vaccines
11/23/2006	WO2006124598A2 Biomass hydrolysate and uses and production thereof
11/23/2006	WO2006124529A1 Glp-1 pegylated compounds
11/23/2006	WO2006124161A1 Sustained release l-arginine formulations and methods of manufacture and use
11/23/2006	WO2006124000A1 Aldehyde conjugated flavonoid preparations
11/23/2006	WO2006123766A1 Film coated preparation containing dextrose
11/23/2006	WO2006123765A1 Film coated preparation
11/23/2006	WO2006123678A1 Stable tablet containing droxidopa
11/23/2006	WO2006123631A1 Rna-containing composition
11/23/2006	WO2006123361A2 Microspheres containing goserelin or a pharmaceutically acceptable salt thereof
11/23/2006	WO2006123360A2 Microspheres containing octreotide acetate
11/23/2006	WO2006123324A1 Topical compositions
11/23/2006	WO2006123173A1 Gelatin-containing topical composition
11/23/2006	WO2006123031A2 Pharmaceutical composition comprising an oleaginous ointment and vitamin d or the derivatives thereof in solubilised form
11/23/2006	WO2006122982A1 New poly(ethylene glycol) derivatives and process for their coupling to proteins
11/23/2006	WO2006122973A1 Composition for treatment of a detached retina and method of production thereof
11/23/2006	WO2006122835A1 Colonic delivery of adsorbents
11/23/2006	WO2006122828A2 Optimized injection formulation for rna
11/23/2006	WO2006122650A2 Isolated aqdecay photoprotein and use thereof
11/23/2006	WO2006122472A1 Antithyroid ointment for external use and the preparation thereof
11/23/2006	WO2006122431A1 Triazine compounds and compositions thereof for the treatment of cancers
11/23/2006	WO2006122414A1 Depot for sustained and controlled delivery of methotrexate
11/23/2006	WO2006122409A1 Antimicrobial molecules and their uses
11/23/2006	WO2006094828A3 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor
11/23/2006	WO2006092230A3 Protein-binding camptothecin peptide derivatives and medicaments comprising the same
11/23/2006	WO2006086107A3 Methods and compositions for minimizing accrual of inhalable insulin in the lungs

1 ... 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 ... 1712